Limitless
Limitless, licence 80053119: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Ikkuma Inc.
- NPN or DIN-HM
- 80053119
- Status
- Active licence
- Licence date
- 14 August 2014
- Revision date
- 13 June 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 15 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Méthylcobalamine | 75.0 mcg | 150 µg |
| Withania somnifera Source : Racine Extraction ratio : 12:1 Dry plant equivalent : 1200 mg Potency : 5.0 mg withanolides | 100.0 mg | Not calculated |
| Vitamine D3 Source : Lanoline Potency : 7.5 mcg | 300.0 UI | 15 µg |
| Folate Source : Folate | 300.0 mcg | Not calculated |
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- Source : Pyrroloquinoline quinone disodium salt | 10.0 milligramme | Not calculated |
Non-medicinal ingredients
Colloidal silicon dioxide, Cellulose microcristalline, Hydroxypropylméthylcellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to enhance cognitive function in adults. Helps to enhance cognitive performance in adults. An antioxidant for the maintenance of good health. Helps in the development and maintenance of bones, teeth, cartilages and gums. Helps in the absorption and use of calcium and phosphorous. Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Helps in connective tissue formation. Helps in wound healing. Helps to support peripheral circulation. Helps to maintain and/or support cardiovascular health . Helps to enhance memory in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053119
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.